INOVIO PHARMACEUTICALS, INC. short interest in 2022
In 2022, INOVIO PHARMACEUTICALS, INC.'s disclosed short interest ran from 21.26% of shares outstanding on 14 Jan 2022 to 17.94% on 30 Dec 2022, a change of -3.32 percentage points. The year's high was 22.88% on 28 Feb 2022 and its low 15.83% on 31 May 2022, averaging 19.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.96 days on 28 Feb 2022. Full history: INOVIO PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 21.26% (14 Jan 2022)
- End of year
- 17.94% (30 Dec 2022)
- Change
- -3.32 pp
- High
- 22.88% (28 Feb 2022)
- Low
- 15.83% (31 May 2022)
- Average
- 19.31%
- Highest days to cover
- 13.96 (28 Feb 2022)
- SEC filings marked
- 7
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 21.26% | 10.84 | |
| 31 Jan 2022 | 22.35% | 9.62 | |
| 15 Feb 2022 | 22.34% | 10.02 | |
| 28 Feb 2022 | 22.88% | 13.96 | |
| 15 Mar 2022 | 21.27% | 10.23 | 10-K filed |
| 31 Mar 2022 | 20.52% | 6.86 | |
| 14 Apr 2022 | 20.87% | 11.39 | |
| 29 Apr 2022 | 20.77% | 12.43 | |
| 13 May 2022 | 19.92% | 6.36 | 10-Q filed, results (8-K) |
| 31 May 2022 | 15.83% | 3.67 | |
| 15 Jun 2022 | 16.52% | 6.43 | |
| 30 Jun 2022 | 18.57% | 4.94 | |
| 15 Jul 2022 | 20.00% | 8.11 | |
| 29 Jul 2022 | 20.10% | 7.17 | |
| 15 Aug 2022 | 18.07% | 6.66 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 18.28% | 8.63 | |
| 15 Sep 2022 | 18.34% | 8.55 | |
| 30 Sep 2022 | 18.01% | 7.73 | |
| 14 Oct 2022 | 18.27% | 10.23 | |
| 31 Oct 2022 | 17.51% | 7.18 | |
| 15 Nov 2022 | 18.50% | 6.14 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 17.34% | 7.85 | |
| 15 Dec 2022 | 18.03% | 8.67 | |
| 30 Dec 2022 | 17.94% | 7.98 |
See also: INOVIO PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.